Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults. This critical Phase 3 trial will be the final clinical step before FDA approval to become a prescribable drug.
Leadership at Jefferson and the Monell Center announced today the signing of a non-binding Letter of Intent (LOI) to move forward with discussions of merging the two organizations.
Two-dimensional representations of complex biological networks are dense, messy, and hard to understand. Researchers at Worcester Polytechnic Institute (WPI) are taming the so-called hairy ball" by using the Microsoft HoloLens, a mixed-reality viewer, to explore these networks in 3-D. They are creating a tool that can enable scientists focus on the most important information and connections which can help with finding critical links between proteins and genes related to complex disorders like cancer and diabetes.
To address the limited clinical opportunities nursing students have to experience palliative care and end-of-life conversations, the University of Houston College of Nursing is now using a high-fidelity mannequin to simulate these challenging interactions.
ExxonMobil Chemical Company and the University of Houston have signed a multi-year research agreement that will focus on helping the industry develop energy-efficient solutions for manufacturing petrochemical products while minimizing their environmental impact.
Researchers from ETH Zurich have built a prototype of an ultra-thin, curved concrete roof using innovative digital design and fabrication methods. The tested novel formwork system will be used in an actual construction project for the first time next year.
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
VTT is coordinating an European project called ESTABLISH, which aims to provide a healthier and safer environment thereby improving the quality of life. The project includes a pilot experiment in Finland, which will be carried out in schools.
Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial in humans for a promising leprosy vaccine candidate -- the first vaccine developed specifically for leprosy.
The National Institutes of Health and 11 leading biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and validate robust biomarkers -- standardized biological markers of disease and treatment response -- to advance new immunotherapy treatments that harness the immune system to attack cancer.